Use of high-dose cortisone in a patient with Marchiafava-Bignami disease [4]

Journal of Neurology

Volumn 250, Issue 6, 2003, Pages 758-760

  Gerlach, Annegrit ^a   Oehm, Eckard ^a   Wattchow, Jens ^a   Ziyeh, Sargon ^a   Glocker, Franz Xaver ^a   Els, Thomas ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE; METHYLPREDNISOLONE; THIAMINE;

AGED; ALCOHOL ABUSE; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CONSCIOUSNESS; CORPUS CALLOSUM; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LETTER; MARCHIAFAVA BIGNAMI DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THIAMINE DEFICIENCY; TREATMENT OUTCOME;

AGED; ALCOHOL-RELATED DISORDERS; ANTI-INFLAMMATORY AGENTS; CORPUS CALLOSUM; DEMYELINATING DISEASES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE;

EID: 0038796574     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-1072-6     Document Type: Letter

References (15)

1. Brion S (1976) Marchiafava-Bignami disease. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 28. North-Holland, Amsterdam New York Oxford, pp 317-329
2. Castaigne P, Buge A, Cambier J, Escourolle R, Bancurel G (1971) La maladie de Marchiafava-Bignami: étude anatomoclinique de dix observations. Rev Neurol (Paris) 125:179-196
3. Chang KH, Cha SA, Han MH, Park SH, Nah DL, Hong JH (1992) Marchiafava-Bignami disease: serial changes in corpus callosum on MRI. Neuroradiology 34:480-482
4. Funabiki Y, Tatsukawa H, Ashida K, Matsubara K, Kubota Y, Uwatoko H, Kitamura K (1998) Disturbance of consciousness associated with hypophosphatemia in a chronically alcoholic patient. Intern Med 37:958-961
5. Hatz HJ (1998) Glucocorticoide. Immunologische Grundlagen, Pharmakologie und Therapierichtlinien. Wissenschaftliche Verlagsgesellschaft, Stuttgart
6. Haukeland JW, Bohmer T (1999) Severe hypophosphatemia - an overlooked condition? Tidsskr Nor Laegeforen 119:538-540
7. Heepe P, Nemeth L, Brune F, Grant JW, Kleihues P (1988) Marchiafava-Bignami disease. A correlative computed tomography and morphological study. Eur Arch Psychiatr Neurol Sci 237:74-79
8. Helenius J, Tatlisumak T, Soinne L, Valanne L, Kaste M (2001) Marchiafava-Bignami Disease: two cases with favourable outcome. Eur J Neurol 8:269-272
9. Kikkawa Y, Takaya Y, Niwa N (2000) A case of Marchiafava-Bignami disease that responded to intravenous corticosteroid administration. Rinsho Shinkeigaku 40:1122-1125
10. Kohler CG, Ances BM, Coleman AR, Ragland JD, Lazarev M, Gur RC (2000) Marchiafava-Bignami disease: literature review and case report. Neuropsychiatry, Neuropsychol Behav Neurol 13:67-76
11. Leussink V, Jung S, Merschdorf U, Toyka K, Gold R (2001) High-Dose Methylprednisolone Therapy in Multiple Sclerosis Induced Apoptosis in Peripheral Blood Leukocytes. Arch Neurol 58:91-97
12. Ruiz-Martinez J, Martinez Pérez-Balsa A, Ruibal M, Urtasun M, Villanua J, Marti Masso JF (1999) Marchiafava-Bignami disease with widespread extracallosal lesions and favourable course. Neuroradiology 41:40-43
13. Shiota J, Nakano I, Kawamura M, Hirayama K (1996) An autopsy case of Marchiafava-Bignami disease with peculiar chronological CT changes in the corpus callosum: neuroradiopathological correlations. J Neurol Sci 136:90-93
14. Weber U, Hüppe T, Niehaus L (2000) CT and MRI in severe hypophosphatemia with central nervous system involvement. Neuroradiology 42:112-114
15. Zurkirchen MA, Misteli M, Conen D (1994) Reversible neurological complications in chronic alcohol abuse with hypophosphatemia. Schweiz Med Wochenschr 124:1807-1812